All Work

Chris Lange

Why the FDA Is Crushing Nabriva’s UTI Treatment

Nabriva Therapeutics shares dropped sharply on Wednesday after the firm received a warning from the FDA for the New Drug Application seeking marketing approval of Contepo (fosfomycin).

Chris Lange · 7 years ago

Good News for Ovarian Cancer Treatment

Hermispherx Biopharma shares shot up on Tuesday after the firm announced significant progress in its Ampligen recurrent ovarian cancer program at the University of Pittsburgh Medical Center.

Chris Lange · 7 years ago

How Apple Did It Again in Q1

Apple reported its fiscal second quarter financial results after the market closed on Tuesday.

Chris Lange · 7 years ago

What to Watch in AMD’s Q1 Report

Advanced Micro Devices is scheduled to release its first-quarter financial results after the markets close on Tuesday.

Chris Lange · 7 years ago

What Held Alphabet Back in Q1

Alphabet released mixed first-quarter financial results after the markets closed on Monday and shares pulled back early Tuesday.

Chris Lange · 7 years ago

McDonald’s Earnings: What to Expect

McDonald’s is set to report its first-quarter financial results before the markets open on Tuesday. At this point analysts are still fairly positive on the stock.

Chris Lange · 7 years ago

How Spotify Pulled Out a Win in Q1

Spotify released mixed first-quarter financial results but rising user and subscriber numbers before the markets opened on Monday.

Chris Lange · 7 years ago

Are the Pinterest and Zoom IPOs Cooling Off?

Pinterest and Zoom Video Communications captured the attention of many investors when they came public last week. Each company saw explosive gains out of the gate on Thursday, but let’s check in on day…

Chris Lange · 7 years ago

Big Pharma Scares Off Short Sellers

The April 15 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks decreased.

Chris Lange · 7 years ago

Short Sellers Hazy on Picking Cannabis Stocks

The April 15 short interest data have been compared with the previous figures, and short interest moves in these selected marijuana stocks were mixed.

Chris Lange · 7 years ago